Children who received general anesthesia for surgery before age 4 had diminished language comprehension, lower IQ and decreased gray matter density in posterior regions of their brain, according to a … Continue Reading Researchers link surgical anesthesia in young children to adverse effects on IQ, brain structure.
First report of world’s first implantable chip capable of measuring metabolites and drugs in real-time.
The future of medicine lies in ever greater precision, not only when it comes to diagnosis but also drug dosage. The blood work that medical staff rely on is generally … Continue Reading First report of world’s first implantable chip capable of measuring metabolites and drugs in real-time.
By uncovering the mechanism by which fibrous tissue cells in the lung multiply, researchers at The Children’s Hospital Los Angeles (CHLA), Keck School of Medicine, Nanjing Drum Tower Hospital, Instituto Nacional de … Continue Reading Researchers map and control pulmonary fibrosis signalling pathway in preclinical trials.
A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that … Continue Reading Precision medicine study reveals new subtype of childhood leukemia.
An experimental drug developed by QuatRx Pharmaceuticals causes loss of weight and fat in a mouse animal model in a new study from researchers at the Houston Methodist Research Institute. Known … Continue Reading Experimental antidiabetic drug ‘browns’ white fat in animal studies.
Researchers identify gene mutation that raises risk of nerve damage in leukemia patients using Vincristine.
Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used … Continue Reading Researchers identify gene mutation that raises risk of nerve damage in leukemia patients using Vincristine.
The increasing prevalence of antibiotic resistance, when infectious bacteria evolve to evade drugs designed to control them, is a pressing public health concern. Each year two million Americans acquire antibiotic-resistant … Continue Reading Researchers identify target against MRSA, gram-positive infections using precision genetics.
The U.S. Food and Drug Administration (FDA) has cleared the EnLite Neonatal TREC Kit for the company PerkinElmer, the first screening test permitted to be marketed by FDA for Severe … Continue Reading The FDA clears the first-ever newborn test to detect Severe Combined Immunodeficiency.
Patients with atrial fibrillation who take the blood thinner Pradaxa (dabigatran) are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new … Continue Reading Higher risk of GI, major bleeding in Atrial Fibrillation patients taking Pradaxa (Dabigatran).
A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart … Continue Reading Prostate cancer medications linked to increased heart-related death risk.
The US FDA has cleared the first ever direct blood test for detection of five yeast pathogens that cause bloodstream infections; Candida albicans and/or Candida tropicalis, Candida parapsilosis, Candida glabrata … Continue Reading FDA clears the world’s first test to identify five yeast pathogens directly from blood.
A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease. … Continue Reading FDA-funded study for one-minute point-of-care anemia test shows promise.
The US FDA has approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The … Continue Reading FDA approves weight-management drug Contrave.
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is … Continue Reading Novel vaccine decreases recurrence in HER2 breast cancer patients.
The US FDA has cleared the NephroCheck test, a first-of-a-kind laboratory test to help determine if critically ill hospitalized patients are at risk of developing moderate to severe acute kidney … Continue Reading The FDA clears first-ever test to assess risk of developing acute kidney injury.
NIH-funded researchers map brain tumour cells disrupting the blood-brain barrier, offering potential avenues for therapy. Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain’s protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumour, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.
Thoughts health innovators?